Human tumor antigens recognized by T lymphocytes - PubMed (original) (raw)

Review

Human tumor antigens recognized by T lymphocytes

T Boon et al. J Exp Med. 1996.

No abstract available

PubMed Disclaimer

Similar articles

• Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells.
  Zarour HM, Kirkwood JM, Kierstead LS, Herr W, Brusic V, Slingluff CL Jr, Sidney J, Sette A, Storkus WJ. Zarour HM, et al. Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):400-5. doi: 10.1073/pnas.97.1.400. Proc Natl Acad Sci U S A. 2000. PMID: 10618430 Free PMC article.
• A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
  Coulie PG, Brichard V, Van Pel A, Wölfel T, Schneider J, Traversari C, Mattei S, De Plaen E, Lurquin C, Szikora JP, Renauld JC, Boon T. Coulie PG, et al. J Exp Med. 1994 Jul 1;180(1):35-42. doi: 10.1084/jem.180.1.35. J Exp Med. 1994. PMID: 8006593 Free PMC article.
• Comparison of various sources of antigen-presenting cells for the generation of GP2-tumor peptide specific cytotoxic T-lymphocytes.
  Peiper M, Goedegebuure PS, Alldinger I, Knoefel WT, Izbicki JR, Eberlein TJ. Peiper M, et al. Anticancer Res. 2002 Nov-Dec;22(6A):3357-63. Anticancer Res. 2002. PMID: 12530087
• Antigens recognized by T-lymphocytes on human tumours.
  Coulie PG, Van den Eynde BJ, van der Bruggen P, Van Pel A, Boon T. Coulie PG, et al. Biochem Soc Trans. 1997 May;25(2):544-8. doi: 10.1042/bst0250544. Biochem Soc Trans. 1997. PMID: 9191153 Review. No abstract available.
• New tumour-restricted melanoma antigens as defined by cytotoxic T-cell responses.
  Parmiani G, Anichini A, Castelli C. Parmiani G, et al. Melanoma Res. 1997 Aug;7 Suppl 2:S95-8. Melanoma Res. 1997. PMID: 9578423 Review.

Cited by

• CAR-T and other adoptive cell therapies for B cell malignancies.
  Lu P, Hill HA, Navsaria LJ, Wang ML. Lu P, et al. J Natl Cancer Cent. 2021 Jul 10;1(3):88-96. doi: 10.1016/j.jncc.2021.07.001. eCollection 2021 Sep. J Natl Cancer Cent. 2021. PMID: 39036373 Free PMC article. Review.
• Characterising the HLA-I immunopeptidome of plasma-derived extracellular vesicles in patients with melanoma.
  Boyne C, Coote A, Synowsky S, Naden A, Shirran S, Powis SJ. Boyne C, et al. J Extracell Biol. 2024 Mar 26;3(3):e146. doi: 10.1002/jex2.146. eCollection 2024 Mar. J Extracell Biol. 2024. PMID: 38939414 Free PMC article.
• Increased coexpression of PD-L1 and IDO1 is associated with poor overall survival in patients with NK/T-cell lymphoma.
  Li Y, Chen K, Chen B, Zeng R, He Y, Wang C, Zhong M, Liu X, Chen X, Xiao L, Zhou H. Li Y, et al. Leukemia. 2024 Jul;38(7):1553-1563. doi: 10.1038/s41375-024-02266-y. Epub 2024 May 23. Leukemia. 2024. PMID: 38783159
• Exploring the evolution of T cell function and diversity across different stages of non-small cell lung cancer.
  Chang CY, Chang SC, Wei YF, Tseng YT, Chou CH, Chen YY, Chen CY, Ye YL. Chang CY, et al. Am J Cancer Res. 2024 Mar 15;14(3):1243-1257. doi: 10.62347/ARYH6451. eCollection 2024. Am J Cancer Res. 2024. PMID: 38590421 Free PMC article.
• What do cancer-specific T cells 'see'?
  Shah S, Al-Omari A, Cook KW, Paston SJ, Durrant LG, Brentville VA. Shah S, et al. Discov Immunol. 2022 Dec 6;2(1):kyac011. doi: 10.1093/discim/kyac011. eCollection 2023. Discov Immunol. 2022. PMID: 38567060 Free PMC article. Review.

References

1. 1. Arch Dermatol. 1987 Aug;123(8):1053-5 - PubMed
2. 1. J Immunol. 1995 Jun 1;154(11):5944-50 - PubMed
3. 1. Transplant Proc. 1988 Apr;20(2):339-41 - PubMed
4. 1. J Biol Chem. 1988 Sep 15;263(26):12820-3 - PubMed
5. 1. Am J Reprod Immunol Microbiol. 1988 Oct;18(2):47-51 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database